Home > Rheumatology > EULAR 2022 > Spondyloarthropathies – Novel Developments > How to treat enthesitis in 2022

How to treat enthesitis in 2022

Presented By
Prof. Dennis McGonagle, University of Leeds, United Kingdom
Conference
EULAR 2022
Trial
Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H
Therapy of enthesitis has clearly advanced over the previous decades. Many biologics have shown to be effective in the resolution of enthesitis, without clear evidence that one class of drug is superior to the other, which was discussed at a EULAR How to Treat session. Enthesitis is defined as inflammation at the site of insertion of muscle or tendon in the bone. It is often located at the Achilles tendon, plantar fascia, elbows, and costochondral joints. However, it may be ubiquitous, which might be challenging to recognise. As Prof. Dennis McGonagle (University of Leeds, United Kingdom) emphasised, enthesitis has a major impact on activities of daily living in patients with psoriatic arthritis (PsA) [1]. This has been shown in the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey that examined the influence of PsA on patients' activities of daily living and unmet treatment needs [2]. It showed that enthesitis ca...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on